Skip to main content
. 2021 Dec;12(6):2846–2853. doi: 10.21037/jgo-21-716

Figure 2.

Figure 2

Kaplan–Meier curves of 128 mCRC patients determined by pre-treatment NLR. (A) PFS of 128 mCRC patients determined by pre-treatment NLR; (B) OS of 128 mCRC patients determined by pre-treatment NLR. PFS, progression-free survival; OS, overall survival; mCRC, metastatic colorectal cancer; NLR, neutrophil-to-lymphocyte ratio.